期刊
JOURNAL OF PATHOLOGY
卷 236, 期 4, 页码 433-444出版社
WILEY-BLACKWELL
DOI: 10.1002/path.4548
关键词
wound healing; diabetes; macrophage; inflammation; resolution of inflammation
资金
- National Institutes of Health (NIH) [R01GM092850]
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092850] Funding Source: NIH RePORTER
Macrophages undergo a transition from pro-inflammatory to healing-associated phenotypes that is critical for efficient wound healing. However, the regulation of this transition during normal and impaired healing remains to be elucidated. In our studies, the switch in macrophage phenotypes during skin wound healing was associated with up-regulation of the peroxisome proliferator-activated receptor (PPAR) and its downstream targets, along with increased mitochondrial content. In the setting of diabetes, up-regulation of PPAR activity was impaired by sustained expression of IL-1 in both mouse and human wounds. In addition, experiments with myeloid-specific PPAR knockout mice indicated that loss of PPAR in macrophages is sufficient to prolong wound inflammation and delay healing. Furthermore, PPAR agonists promoted a healing-associated macrophage phenotype both in vitro and in vivo, even in the diabetic wound environment. Importantly, topical administration of PPAR agonists improved healing in diabetic mice, suggesting an appealing strategy for down-regulating inflammation and improving the healing of chronic wounds. Copyright (c) 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据